Australia's CSL Agrees To Buy Vifor Pharma For $11.7 Bln In Cash - Quick Facts
14/12 07:10
(RTTNews) - Australian biotech company CSL Ltd. (CSL.AX, CMXHF.PK) announced Tuesday its definitive agreement to acquire Swiss drugmaker Vifor Pharma Ltd. for an aggregate equity value of $11.7 billion or about 10.9 billion Swiss francs....